Novus Biologicals Investments

Novus Biologicals has invested in 1 company and its latest investment was Ablative on Jan 02, 2019

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Ablative is a California-based medical device company that develops and manufactures peregrine infusion systems for the treatment of hypertension.
$77M
Jan 02, 2019
-